Mount Sinai School of Medicine received a $200 million pledge from billionaire investor Carl Icahn. The greatest part of the funding will go towards building general medical research capabilities as well as specific research in the growing field of Genomics.
2017 Life Science R&D Expenditures: $575,448,000
2017 R&D NIH Funding Rank: 40th
2018 NIH Funding: $345,221,510
Researchers from the Icahn School of Medicine were awarded more $8 million from NIH in 2018, to investigate the effects of a broad range of environmental exposures on the origins of maladaptive neurodevelopment in children. The project has received over $18.5 million in funding since 2016.
The NIH has awarded $15.5 million to a research team at the Icahn School of Medicine to map the molecular changes in the body during physical activity.
The Dengue Human Immunology Project Consortium at Mount Sinai was awarded $7.3 million in 2018 from NIH, to research immune response during or following dengue virus infection, and before or after vaccination with attenuated dengue virus.
Demonstrate Your Research Products at the Mount Sinai Event
Last year, the BioResearch Product Faire™ Event at the Mount Sinai School of Medicine attracted 252 attendees. Of these attendees 91 were purchasing agents, professors and post docs. 7 were lab managers. These attendees came from 10 different research buildings and 40 on-campus departments.
Explore your laboratory sales connection opportunities by participating in this highly anticipated New York event.